SEARCH

MEDIA PACK

NEWS

Current Edition

Aspaveli

After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli

After rare disease drugmaker Sobi reportedly had a buyout scuppered by pharma giant AstraZeneca, the company has picked up a win that stands to bolster …

10 December 2021 Regional News Aspaveli disease

Continue Reading →

Europe

InSciTe project that targets new way to take eye medicines enters clinical studies

One of the projects of the Chemelot Institute for Science and Technology (InSciTe, The Netherlands) has been granted permission by the ‘Dutch Health and Youth …

13 June 2018 Europe eye InSciTe

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli

InSciTe project that targets new way to take eye medicines enters clinical studies

Journal for Clinical Studies